Semax peptide has emerged as a compelling subject in modern neuroscience research due to its unique structural design and potential interaction with neurobiological pathways. Originally developed in Russia and studied through institutions such as the Russian Academy of Sciences, Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) fragments. Scientific investigations suggest that it may influence neurotrophic factors, neuronal signaling mechanisms, and synaptic plasticity, making it a valuable molecular tool for exploring cognitive function and neural adaptability.